Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03903510 · ClinicalTrials.gov registry record · NA

Virtual Reality During Pediatric Cast Removal

A NA study of Fractures, Bone, sponsored by Gillette Children's Specialty Healthcare.

Recruiting
Registry status
NA
Development phase
184
Enrollment target
1
Study location

NCT03903510: Recruiting NA study of Fractures, Bone, sponsored by Gillette Children's Specialty Healthcare.

NCT03903510 is a NA study of Fractures, Bone that is actively recruiting participants, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 184 participants, below the 1,930-participant average among 12 other Fractures, Bone trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03903510, a NA study of Fractures, Bone, is actively recruiting participants, sponsored by Gillette Children's Specialty Healthcare.

RECRUITING
Registry status
NA
Development phase
184 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized control trial of Virtual Reality during cast removal procedures at a pediatric tertiary care center.

Primary Outcome

The change from baseline heart rate during cast removal procedure obtained by using an electronic monitoring wristband and measuring heart rate 15 seconds prior to and continuously during the cast removal procedure.

Conditions Studied

Interventions

  • DEVICE Virtual Reality (VR)

Study Locations (1)

Minnesota

  • Gillette Children's Specialty Healthcare - Saint Paul

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2019-05-21
Est. Completion 2021-09
Phase NA

What NCT03903510 shows while recruiting

NCT03903510 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,930-participant average among 12 other Fractures, Bone trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Fractures, Bone appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality (VR) is the first listed.

NCT03903510 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT03903510 about?

NCT03903510 is a clinical study titled "Virtual Reality During Pediatric Cast Removal". This study is a randomized control trial of Virtual Reality during cast removal procedures at a pediatric tertiary care center.

What is the current status of trial NCT03903510?

This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2019-05-21. Estimated completion is 2021-09.

What conditions does trial NCT03903510 study?

This clinical trial studies the following conditions: Fractures, Bone.

What interventions are being tested in trial NCT03903510?

The interventions under investigation include: Virtual Reality (VR) (DEVICE).

Who is sponsoring clinical trial NCT03903510?

This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03903510 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fractures, Bone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03903510's enrollment target sits among peer trials

184 5th of 12 higher than 8 of 12 other Fractures, Bone trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fractures, Bone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020510 · 184 participants · Phase 4

    Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

  • NCT04135846 · 184 participants · Phase 2

    Alpha-1 Blockade for Alcohol Use Disorder (AUD)

  • NCT04396873 · 184 participants · Phase 1

    PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

  • NCT04700332 · 184 participants · Phase 2

    PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03903510, the US trial registry maintained by the National Library of Medicine. NCT03903510 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.